Literature DB >> 24861435

Demethylation within the proximal promoter region of human estrogen receptor alpha gene correlates with its enhanced expression: Implications for female bias in lupus.

Hong-Wen Liu1, Hui-Li Lin2, Jeng-Hsien Yen3, Wen-Chan Tsai3, Shyh-Shin Chiou4, Jan-Gowth Chang5, Tsan-Teng Ou6, Cheng-Chin Wu6, Nien-Chan Chao7.   

Abstract

Systemic lupus erythematosus (SLE) is a systemic autoimmune disease primarily affecting women. Previous studies have indicated that sex hormone estrogens contribute to the female predilection of SLE. Estrogen regulates gene expression by translocating estrogen receptors (ER) α and β into the nucleus where they induce transcription by binding to estrogen response elements of target genes. We have previously observed that expression of ERα gene and protein in lupus patients is significantly higher than in healthy controls and that estradiol up-regulates calcineurin expression via over-expression of ERα gene in SLE. However, the pathogenesis of over-expression of ERα gene is unknown. Here we report that enhanced expression of ERα mRNA and protein in SLE and rheumatoid arthritis is associated with DNA demethylation within the proximal promoter region located between -232 and +81 base pair relative to transcription start site of human ERα gene (GenBank Accession no. AL356311.6). The frequency of DNA demethylation was comparable between male and female. These findings suggest that estrogen and demethylated ERα promoter associated up-regulated ERα genes are two critical factors in the gender biased development of autoimmune diseases besides genetic factor.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Estrogen; Estrogen receptor alpha; Female bias; Promoter demethylation; Rheumatoid arthritis; Systemic lupus erythematosus

Mesh:

Substances:

Year:  2014        PMID: 24861435     DOI: 10.1016/j.molimm.2014.05.002

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  9 in total

Review 1.  DNA methylation in systemic lupus erythematosus.

Authors:  Christian M Hedrich; Katrin Mäbert; Thomas Rauen; George C Tsokos
Journal:  Epigenomics       Date:  2016-11-25       Impact factor: 4.778

2.  Hypoxia Represses ER-α Expression and Inhibits Estrogen-Induced Regulation of Ca2+-Activated K+ Channel Activity and Myogenic Tone in Ovine Uterine Arteries: Causal Role of DNA Methylation.

Authors:  Man Chen; Daliao Xiao; Xiang-Qun Hu; Chiranjib Dasgupta; Shumei Yang; Lubo Zhang
Journal:  Hypertension       Date:  2015-05-18       Impact factor: 10.190

3.  The S100A7 nuclear interactors in autoimmune diseases: a coevolutionary study in mammals.

Authors:  Fabio D'Amico; Evangelia Skarmoutsou; Massimo Libra
Journal:  Immunogenetics       Date:  2022-02-16       Impact factor: 2.846

Review 4.  DNA methylation alterations in the pathogenesis of lupus.

Authors:  S H Chen; Q L Lv; L Hu; M J Peng; G H Wang; B Sun
Journal:  Clin Exp Immunol       Date:  2016-11-01       Impact factor: 4.330

Review 5.  Epigenetics in SLE.

Authors:  Christian Michael Hedrich
Journal:  Curr Rheumatol Rep       Date:  2017-09       Impact factor: 4.592

Review 6.  The Pathogenic Role of Dysregulated Epigenetic Modifications in Autoimmune Diseases.

Authors:  Haijing Wu; Yongjian Chen; Huan Zhu; Ming Zhao; Qianjin Lu
Journal:  Front Immunol       Date:  2019-09-27       Impact factor: 7.561

Review 7.  Contribution of Dysregulated DNA Methylation to Autoimmunity.

Authors:  Samanta C Funes; Ayleen Fernández-Fierro; Diego Rebolledo-Zelada; Juan P Mackern-Oberti; Alexis M Kalergis
Journal:  Int J Mol Sci       Date:  2021-11-02       Impact factor: 5.923

8.  Sex hormones affect the pathogenesis and clinical characteristics of systemic lupus erythematosus.

Authors:  Ji-Won Kim; Hyoun-Ah Kim; Chang-Hee Suh; Ju-Yang Jung
Journal:  Front Med (Lausanne)       Date:  2022-08-11

Review 9.  Regulation of the germinal center response by nuclear receptors and implications for autoimmune diseases.

Authors:  William J Olson; Bojana Jakic; Natascha Hermann-Kleiter
Journal:  FEBS J       Date:  2020-04-19       Impact factor: 5.542

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.